Parkinson's disease (PD) is a progressive neurodegenerative disorder that currently has no
cure, but treatments are available to improve PD symptoms and maintain quality of life. In …

Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARS-Cov-2
pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID …

Transfusion transmissible infections (TTIs), caused by hepatitis B virus (HBV), human
immunode-ficiency virus (HIV), hepatitis C virus (HCV), and syphilis, have a high global …

Background and objectives COVID‐19 convalescent plasma is an experimental treatment
against SARS‐CoV‐2. The aim of this study is to assess the impact of different pathogen …

Industrial plasma fractionation, a complex and highly regulated technology, remains largely
inaccessible to many low‐and middle‐income countries (LMICs). This, combined with the …

The rare congenital bleeding disorders are a heterogeneous group of diseases which
include deficiencies of fibrinogen, prothrombin and factors V, V+ VIII, VII, X, XI and XIII. They …

Violet–blue light of 405 nm in the visible spectrum at a dose of 270 J/cm2 alone has been
shown to be an effective microbicidal tool for inactivating several bacteria, HIV-1, and …

Efforts and processes to ensure safety of the blood supply are critical and widespread in
transfusion medicine. Positive patient identification for type and screens and crossmatches …

Enveloped viruses pose a critical health threat to human beings. Photodynamic inactivation
shows promise but requires a relatively long time of irradiation or a high power intensity …

Background In June 2017, Israel lifted the ban on blood donations from men who have sex
with men (MSM) and accepts donations if 12 months have passed since the last sexual …